CORRELATION OF TERATOGENICITY OF ASPIRIN TO THE STAGESPECIFIC DISTRIBUTION OF SALICYLIC ACID IN RATS

A study was made of the stage-specific teratogenicity in rat fetuses from dams given different dosages of aspirin throughout and also during 3 subdivided organogenetic periods of pregnancy (days 8-10, 11-13 and 15-17 of gestation). The stage-specific teratogenicity of the drug, from the aspect of th...

Full description

Saved in:
Bibliographic Details
Published inJapanese journal of pharmacology Vol. 31; no. 4; pp. 563 - 571
Main Authors TAGASHIRA, Eijiro, NAKAO, Kenzo, URANO, Tomoko, ISHIKAWA, Shigeru, HIRAMORI, Tameo, YANAURA, Saizo
Format Journal Article
LanguageEnglish
Published The Japanese Pharmacological Society 1981
Online AccessGet full text

Cover

Loading…
Abstract A study was made of the stage-specific teratogenicity in rat fetuses from dams given different dosages of aspirin throughout and also during 3 subdivided organogenetic periods of pregnancy (days 8-10, 11-13 and 15-17 of gestation). The stage-specific teratogenicity of the drug, from the aspect of the dam-fetus distribution pattern of salicylic acid during the respective periods of pregnancy was also determined. The stage when the malformations, typical of aspirin toxicity (cranioschisis, spondyloschisis, abdominal fissure, cleft palate) were most frequent was from day 8 to day 10 of gestation. Even in this period when the fetuses were most susceptible to this teratogen, however, the drug was not teratogenic unless it was ingested for 3 or more consecutive days. There were no significant alterations in the maternal plasma levels of salicylic acid during the respective periods. During the first 8-10 days of gestation, the fetal levels of salicylic acid remained significantly high (p<0.05) at any stage of measurement during the 10 hours after application of aspirin, compared with the maternal plasma levels. Furthermore, as pregnancy progressed, the amount of salicylic acid transferred to the fetuses tended to gradually decrease, despite of the fact that the maternal plasma levels of the agent remained fairly stable. On the other hand, the placental levels of salicylic acid tended to be increasingly elevated with the pregression of pregnancy. Thus, salicylic acid is most readily transferred to the fetuses at high concentrations at days 8-10 of gestation. Also, from the finding that aspirin proved to be teratogenic when the fetuses were exposed to a given period (3 days or more), the teratogenic action of aspirin is attributed to a direct action of this compound.
AbstractList A study was made of the stage-specific teratogenicity in rat fetuses from dams given different dosages of aspirin throughout and also during 3 subdivided organogenetic periods of pregnancy (days 8-10, 11-13 and 15-17 of gestation). The stage-specific teratogenicity of the drug, from the aspect of the dam-fetus distribution pattern of salicylic acid during the respective periods of pregnancy was also determined. The stage when the malformations, typical of aspirin toxicity (cranioschisis, spondyloschisis, abdominal fissure, cleft palate) were most frequent was from day 8 to day 10 of gestation. Even in this period when the fetuses were most susceptible to this teratogen, however, the drug was not teratogenic unless it was ingested for 3 or more consecutive days. There were no significant alterations in the maternal plasma levels of salicylic acid during the respective periods. During the first 8-10 days of gestation, the fetal levels of salicylic acid remained significantly high (p<0.05) at any stage of measurement during the 10 hours after application of aspirin, compared with the maternal plasma levels. Furthermore, as pregnancy progressed, the amount of salicylic acid transferred to the fetuses tended to gradually decrease, despite of the fact that the maternal plasma levels of the agent remained fairly stable. On the other hand, the placental levels of salicylic acid tended to be increasingly elevated with the pregression of pregnancy. Thus, salicylic acid is most readily transferred to the fetuses at high concentrations at days 8-10 of gestation. Also, from the finding that aspirin proved to be teratogenic when the fetuses were exposed to a given period (3 days or more), the teratogenic action of aspirin is attributed to a direct action of this compound.
Author TAGASHIRA, Eijiro
HIRAMORI, Tameo
URANO, Tomoko
YANAURA, Saizo
NAKAO, Kenzo
ISHIKAWA, Shigeru
Author_xml – sequence: 1
  fullname: TAGASHIRA, Eijiro
  organization: Department of Pharmacology, Hoshi College of Pharmacy
– sequence: 2
  fullname: NAKAO, Kenzo
  organization: Department of Pharmacology, Hoshi College of Pharmacy
– sequence: 3
  fullname: URANO, Tomoko
  organization: Department of Pharmacology, Hoshi College of Pharmacy
– sequence: 4
  fullname: ISHIKAWA, Shigeru
  organization: Department of Pharmacology, Hoshi College of Pharmacy
– sequence: 5
  fullname: HIRAMORI, Tameo
  organization: Department of Pharmacology, Hoshi College of Pharmacy
– sequence: 6
  fullname: YANAURA, Saizo
  organization: Department of Pharmacology, Hoshi College of Pharmacy
BookMark eNo9kD9vwjAQxa2KSgXapZ_Ac6VQO7bzZ0xNAEsRQYkZmCzj2IWIAkpY-PY1omW4O93d773hjcDgeDpaAN4xmuCQ0c-2PU8InrCIPIEhJjQOCEPRAAwRCnHAcJq8gFHft35NEKZD0PCyqvIik6JcwnIGZV5lspznS8GF3NwuWb0SlVhCWUK5yGEts3ler3IuZoLDqahlJb7W__I6KwTf-IIZF1PoZd6ufgXPTh96-_Y3x2A9yyVfBEU5FzwrAkMJIQG2FOkwdZFOHTaGhhGiyGmUbomLXRw2ljTWYpsYk0YsZluCTGMdY6xJULxlZAw-7r6mO_V9Z506d_sf3V0VRuqWj_L5KIKVz8fD0zvc9hf9bR-o7i57c7CqPe96nDJ84-m9ednjbXa6U_ZIfgFq_mpm
CitedBy_id crossref_primary_10_1002_tera_1420300113
crossref_primary_10_3389_fcell_2020_592967
crossref_primary_10_1002_jez_1069
crossref_primary_10_1038_323276a0
crossref_primary_10_1177_096032719401300204
ContentType Journal Article
Copyright The Japanese PharmacologicalSociety
Copyright_xml – notice: The Japanese PharmacologicalSociety
DBID AAYXX
CITATION
DOI 10.1254/jjp.31.563
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1347-3506
EndPage 571
ExternalDocumentID 10_1254_jjp_31_563
article_jphs1951_31_4_31_4_563_article_char_en
GroupedDBID .55
.GJ
08R
123
29J
2WC
3O-
41~
53G
5RE
AABQG
AAEDW
AALRI
AAUGY
AAXUO
ACLIJ
ADBBV
AITUG
AL-
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
CS3
DIK
E3Z
EBS
F5P
FDB
HH5
JMI
JSF
JSH
KQ8
MOJWN
M~E
NCXOZ
OK1
RJT
RZJ
TKC
TR2
W2D
X7J
X7M
XSB
ZGI
ZXP
0SF
AAYXX
ADVLN
AKRWK
CITATION
ID FETCH-LOGICAL-c4333-1e40a29f6a9f1cc426040fa09b3f7f72de3dee1e8cc96575b30cdef555d807b53
ISSN 0021-5198
IngestDate Fri Aug 23 00:49:04 EDT 2024
Thu Aug 17 20:29:11 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4333-1e40a29f6a9f1cc426040fa09b3f7f72de3dee1e8cc96575b30cdef555d807b53
OpenAccessLink https://www.jstage.jst.go.jp/article/jphs1951/31/4/31_4_563/_article/-char/en
PageCount 9
ParticipantIDs crossref_primary_10_1254_jjp_31_563
jstage_primary_article_jphs1951_31_4_31_4_563_article_char_en
PublicationCentury 1900
PublicationDate 1981-00-00
PublicationDateYYYYMMDD 1981-01-01
PublicationDate_xml – year: 1981
  text: 1981-00-00
PublicationDecade 1980
PublicationTitle Japanese journal of pharmacology
PublicationTitleAlternate Jpn.J.Pharmacol.
PublicationYear 1981
Publisher The Japanese Pharmacological Society
Publisher_xml – name: The Japanese Pharmacological Society
References 11) Obbink, H.J.K. and Dalderup, L.M.: Effect of acetylsalicylic acid on foetal mice and rats. Lancet I, 565 (1964
3) Nagahama, M., Akiyama, N. and Miki, T.: Experimental production of malformations due to salicylates (acetyl salicylate and phenyl salicylate) in rats. Cong. Anom. 6, 20-27 (1966
7) Koshakji, R.P. and Schulert, A.P.: Biochemical mechanisms of salicylate teratology in the rat. Biochem. Pharmacol. 22, 407-416 (1973
15) Shapiro, S., Siskind, V., Monson, R.R., Heinonen, O.P., Kaufman, D.W. and Slone, D.: Perinatal mortality and birthweight in relation to aspirin taken during pregnancy. Lancet I, 1375-1376 (1976
17) Wilson, J.G.: Use of rhesus monkeys in teratological studies. Fedn. Proc. 30, 104-109 (1971
1) Warkany, J. and Takacs, E.: Experimental production of congenital malformations in rats by salicylate poisoning. Am. J. Pathol. 35, 315-330 (1959
9) Miyamoto, T. and Nagahama, M.: Experimental studies of congenital hydrops induced by acetyl salicylate (aspirin) in rats. Cong. Anom. 7, 167 (1967
13) Turner, G. and Collins, E.: Fetal effects of regular salicylate ingestion in pregnancy. Lancet II, 338-339 (1975
18) Beck, F., Lloyd, J.B. and Griffiths, A.: Lysosomal enzyme inhibition by trypan blue: A theory of teratogenesis. Science 157, 1180-1182 (1967
12) Collins, E. and Turner, G.: Maternal effects of regular salicylate ingestion in pregnancy. Lancet II, 335-337 (1975
4) Tanaka, S., Kawashima, K., Nakaura, S., Nagao, S., Kuwamura, T., Takanaka, A. and Omori, Y.: Studies on teratogenic effects of salicylic acid and aspirin in rats as related to fetal distribution. Cong. Anom. 13, 73-84 (1973
14) Slone, D., Siskind, V., Heinonen, O.P., Monson, R.R., Kaufman, D.W. and Shapiro, S.: Aspirin and congenital malformations. Lancet I, 1373-1375 (1976
16) Collins, E. and Turner, G.: Aspirin during pregnancy. Lancet II, 797-798 (1976
2) Nagahama, M., Akiyama, N. and Miki, T.: Experimental production of malformations due salicylates (acetyl salicylate and phenyl salicylate) in rats. Cong. Anom. 5, 236-237 (1965
8) Akiyama, N. and Nagahama, M.: Embryological studies on the congenital skeletal anomalies induced by acetyl salicylate (aspirin) in rats. Cong. Anom. 6, 171 (1966
10) Goldman, A.S. and Yakovac, W.C.: Salicylate intoxication and congenital anomalies. Arch. Environmt. Health 8, 648-656 (1964
5) Blattner, R.J.: Teratogenic action of salicylate in mice: Effect on mucopoly saccharide synthesis. J. Pediat. 66, 1102-1104 (1965
6) Kimmel, C.A., Wilson, J.G. and Schumacher, H.T.: Studies on metabolism and identification of the causative agent in aspirin teratogenesis in rats. Teratology 4, 15-24 (1971
References_xml
SSID ssj0028014
Score 1.1862442
Snippet A study was made of the stage-specific teratogenicity in rat fetuses from dams given different dosages of aspirin throughout and also during 3 subdivided...
SourceID crossref
jstage
SourceType Aggregation Database
Publisher
StartPage 563
Title CORRELATION OF TERATOGENICITY OF ASPIRIN TO THE STAGESPECIFIC DISTRIBUTION OF SALICYLIC ACID IN RATS
URI https://www.jstage.jst.go.jp/article/jphs1951/31/4/31_4_563/_article/-char/en
Volume 31
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX The Japanese Journal of Pharmacology, 1981, Vol.31(4), pp.563-571
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FwoEL4inKSyuBeqqD17uO4wMHqwJSIkrVOqI3y95H6xTiKI8D_RH8Zma8ZrOhHAqXVbSesWXPl9mZ3XkQ8oZLGZYyioNQKB2IpDJBBStBoLRK8RwmFW3_lM9Hg9FEfDqLz3q9n17U0npV9eXVX_NK_keqMAdyxSzZf5CsuylMwG-QL4wgYRhvJOMDbK3xzRl9bYHkBqhr2QVaZHiOjpGM1sAES_BcY24lxgfh2Yxrd4XEyxJLBGPR61LWqk10KW2dJ2e9wsqKHSv9ehPzTe1rtzufZx-z09HhSdZq2npaLxq36ZyNsy9dQtCVm52cZEftbN58by7dNG6mjbOv7W1OL-pzvVhvdilYaruwuHwBFoCdaLWstmqWC1BtcTjw9TBnHt6Ep1TjTgXa9Tm2LVuuqX7wdFH1T-d9zvqOxa-v_ce656IR0Q8C7gJ4C84K4L1FbkcJeI5oZB-OnQOPlXZsyJB9o67cLfC-3Tx3y8C5M20l65ks-X1yr_M1aGaB84D09Owh2Tu2AvuxT_NN7t1yn-7RY0-Uj4jy0EUbQ7fRhTMduuiqoYAuuoUu6qMLiR26KKKLAhui6zGZfHifH4yCridHIAXnPGBahGWUmkGZGiYl9jcQoSnDtOImMUmkNFdaMz2UMsUzvYqHUmkTx7EahkkV8ydkZ9bM9FNCpYkZVypKpI5EAheHQlVlKRPQEqaSape8_v0hi7ktvVJcF9UueWe_saPp_o7FdH6xZOBAIKGwA9C7y5jVCErk2Y2e8pzcRVTbvbcXZGe1WOuXYI2uqlctRH4ByUSSLw
link.rule.ids 315,786,790,4043,27956,27957,27958
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correlation+of+teratogenicity+of+Aspirin+to+the+stagespecific+distribution+of+salicylic+acid+in+rats&rft.jtitle=Japanese+journal+of+pharmacology&rft.au=TAGASHIRA%2C+Eijiro&rft.au=NAKAO%2C+Kenzo&rft.au=URANO%2C+Tomoko&rft.au=ISHIKAWA%2C+Shigeru&rft.date=1981&rft.issn=0021-5198&rft.eissn=1347-3506&rft.volume=31&rft.issue=4&rft.spage=563&rft.epage=571&rft_id=info:doi/10.1254%2Fjjp.31.563&rft.externalDBID=n%2Fa&rft.externalDocID=10_1254_jjp_31_563
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5198&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5198&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5198&client=summon